These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10714019)

  • 1. Clinical experience of Argatroban for anticoagulation in cardiovascular surgery.
    Ohteki H; Furukawa K; Ohnishi H; Narita Y; Sakai M; Doi K
    Jpn J Thorac Cardiovasc Surg; 2000 Jan; 48(1):39-46. PubMed ID: 10714019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Argatroban as a potential anticoagulant in cardiopulmonary bypass-studies in a dog model.
    Sakai M; Ohteki H; Narita Y; Naitoh K; Natsuaki M; Itoh T
    Cardiovasc Surg; 1999 Mar; 7(2):187-94. PubMed ID: 10353669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of argatroban, direct thrombin inhibitor, in heparin-intolerant patients requiring extracorporeal circulation.
    Matsuo T; Koide M; Kario K
    Artif Organs; 1997 Sep; 21(9):1035-8. PubMed ID: 9288875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case series describing the use of argatroban in patients on extracorporeal circulation.
    Cornell T; Wyrick P; Fleming G; Pasko D; Han Y; Custer J; Haft J; Annich G
    ASAIO J; 2007; 53(4):460-3. PubMed ID: 17667231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the optimal anticoagulation level with argatroban during percutaneous coronary intervention?
    Cruz-Gonzalez I; Sanchez-Ledesma M; Osakabe M; Watanabe H; Baron SJ; Healy JL; Yeh RW; Jang IK
    Blood Coagul Fibrinolysis; 2008 Jul; 19(5):401-4. PubMed ID: 18600089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Argatroban for elective percutaneous coronary intervention: the ARG-E04 multi-center study.
    Rössig L; Genth-Zotz S; Rau M; Heyndrickx GR; Schneider T; Gulba DC; Desaga M; Buerke M; Harder S; Zeiher AM;
    Int J Cardiol; 2011 Apr; 148(2):214-9. PubMed ID: 20226548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Argatroban as a substitute of heparin during cardiopulmonary bypass: a safe alternative?
    Follis F; Filippone G; Montalbano G; Floriano M; Lobianco E; D'Ancona G; Follis M
    Interact Cardiovasc Thorac Surg; 2010 Apr; 10(4):592-6. PubMed ID: 20061338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic activity of argatroban in experimental thrombosis in the rabbit.
    Berry CN; Girard D; Girardot C; Lochot S; Lunven C; Visconte C
    Semin Thromb Hemost; 1996; 22(3):233-41. PubMed ID: 8836007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of argatroban as an anticoagulant for intermittent veno-venous hemofiltration (IVVH) in patients at high risk of bleeding.
    Sun X; Chen Y; Xiao Q; Wang Y; Zhou J; Ma Z; Xiang J; Chen X
    Nephrol Dial Transplant; 2011 Sep; 26(9):2954-9. PubMed ID: 21303963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anticoagulant efficacy and safety of argatroban for patients undergoing elective percutaneous coronary intervention].
    Tian F; Yu H; Chen YD; Liu HB; Guo J; Sun ZJ; Jin QH; Yan F; Ma YL; Gu XF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Jun; 41(6):480-3. PubMed ID: 24113039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bleeding complications after cardiac surgery, before anticoagulation start and then with argatroban or heparin in the early postoperative setting.
    Klingele M; Enkel J; Speer T; Bomberg H; Baerens L; Schäfers HJ
    J Cardiothorac Surg; 2020 Jan; 15(1):27. PubMed ID: 31992340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical application of argatroban as an alternative anticoagulant for extracorporeal circulation.
    Kawada T; Kitagawa H; Hoson M; Okada Y; Shiomura J
    Hematol Oncol Clin North Am; 2000 Apr; 14(2):445-57, x. PubMed ID: 10806566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin-Induced Thrombocytopenia in Infants after Heart Surgery.
    Abdillah JN; Hu Q; Chen X; Chen X; Zhou W; Luo W; Huang L
    Thorac Cardiovasc Surg; 2019 Jan; 67(1):21-27. PubMed ID: 29605959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Argatroban anticoagulation for heparin-induced thrombocytopenia in elderly patients.
    Bartholomew JR; Pietrangeli CE; Hursting MJ
    Drugs Aging; 2007; 24(6):489-99. PubMed ID: 17571914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Argatroban in extracorporeal membrane oxygenation.
    Beiderlinden M; Treschan T; Görlinger K; Peters J
    Artif Organs; 2007 Jun; 31(6):461-5. PubMed ID: 17537058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intraoperative management for a patient with heparin-induced thrombocytopenia (HIT) undergoing off-pump coronary bypass surgery using argatroban, a direct thrombin inhibitor].
    Ohno H; Yokoi M
    Masui; 2002 Jan; 51(1):30-3. PubMed ID: 11840659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Management of cardiopulmonary bypass during cardiac surgery for patients with heparin-induced thrombocytopenia].
    Kondo T; Hirota M; Hoshino J; Fukada Y; Isomura T
    Kyobu Geka; 2013 May; 66(5):366-9. PubMed ID: 23674032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Argatroban use during pediatric interventional cardiac catheterization.
    Cetta F; Graham LC; Wrona LL; Arruda MJ; Walenga JM
    Catheter Cardiovasc Interv; 2004 Jan; 61(1):147-9. PubMed ID: 14696176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of diagnostic tests and argatroban or lepirudin therapy in patients with suspected heparin-induced thrombocytopenia.
    Kiser TH; Jung R; MacLaren R; Fish DN
    Pharmacotherapy; 2005 Dec; 25(12):1736-45. PubMed ID: 16305293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of argatroban for extracorporeal life support in patients with nonheparin-induced thrombocytopenia: Analysis of 10 consecutive patients.
    Kim YS; Lee H; Yang JH; Sung K; Suh GY; Chung CR; Yang JH; Cho YH
    Medicine (Baltimore); 2018 Nov; 97(47):e13235. PubMed ID: 30461625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.